Clinical trial registry record

Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated December 11, 2017.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03368872
Last registry update
December 11, 2017
Status
Completed
Phase
Phase not reported
Sponsor
Astavita, Inc.
Enrollment
41
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · TREATMENT · QUADRUPLE
Evidence population
Human clinical study registration
Participants
41
Population
ALL · 65 Years to 85 Years
Duration
2015-10-01 to 2016-08-01
Intervention
Astaxanthin formulation; Placebo; Exercise training
Comparator
Placebo and exercise
Outcomes measured
Skeletal muscle strength and performance measured by 31P-magnetic resonance spectroscopy (31p MRS) — Day 30 - Day 120; Muscle energetics — Day 30-Day 120; Hand grip strength — Day 30-Day120; 6-minute walk test — Day 30-Day 120; Safety Measures — Baseline-Day 30-Day 120
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Sarcopenia · 100%Title contains controlled term: sarcopenia. Abstract contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: elderly. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

sarcopenia
Open primary sourceExport JSON